[13], and the Dutch study did not report BRCA1/2 mutations in their study population [12], though others reported very significant regional differences in BRCA1/2 mutations even within this relatively small country [17]. The individual BRCA1/2 mutations in here reported ovarian cancer patients are reported in the Table 3, and also demonstrated no significant overlap with either Austrian or Italian studies. Here, BRCA1 is linked to ovarian cancer.